Chapy Venkatesan

1.8k total citations · 1 hit paper
24 papers, 1.4k citations indexed

About

Chapy Venkatesan is a scholar working on Epidemiology, Hepatology and General Health Professions. According to data from OpenAlex, Chapy Venkatesan has authored 24 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Epidemiology, 16 papers in Hepatology and 5 papers in General Health Professions. Recurrent topics in Chapy Venkatesan's work include Liver Disease Diagnosis and Treatment (15 papers), Liver Disease and Transplantation (12 papers) and Hepatitis C virus research (4 papers). Chapy Venkatesan is often cited by papers focused on Liver Disease Diagnosis and Treatment (15 papers), Liver Disease and Transplantation (12 papers) and Hepatitis C virus research (4 papers). Chapy Venkatesan collaborates with scholars based in United States. Chapy Venkatesan's co-authors include Zobair M. Younossi, Alita Mishra, Munkhzul Otgonsuren, Linda Henry, Madeline Erario, Sharon Hunt, Maria Stepanova, Pegah Golabi, Sammy Saab and Saleh A. Alqahtani and has published in prestigious journals such as Gastroenterology, PLoS ONE and Hepatology.

In The Last Decade

Chapy Venkatesan

22 papers receiving 1.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Association of nonalcoholic fatty liver disease (NAFLD) with hepatocellular carcinoma (HCC) in the United States from 2004 to 2009

2015 593 citations Zobair M. Younossi, Munkhzul Otgonsuren et al. Hepatology profile →

Peers

Countries citing papers authored by Chapy Venkatesan

Since Specialization

Citations

This map shows the geographic impact of Chapy Venkatesan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chapy Venkatesan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chapy Venkatesan more than expected).

Fields of papers citing papers by Chapy Venkatesan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chapy Venkatesan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chapy Venkatesan. The network helps show where Chapy Venkatesan may publish in the future.

Co-authorship network of co-authors of Chapy Venkatesan

This figure shows the co-authorship network connecting the top 25 collaborators of Chapy Venkatesan. A scholar is included among the top collaborators of Chapy Venkatesan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chapy Venkatesan. Chapy Venkatesan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Outcomes of hospitalized patients with COVID-19 during the course of the pandemic in a fully integrated health system 2022 ·PLoS ONE ·Brian Lam, Maria Stepanova, Chapy Venkatesan, (unknown), (unknown), (unknown), (unknown), Mehul J. Desai, Andrei Racila, (unknown), Linda Henry, Lynn H. Gerber, Zobair M. Younossi	5
2	The impact of variants and vaccination on the mortality and resource utilization of hospitalized patients with COVID-19 2022 ·BMC Infectious Diseases ·Maria Stepanova, Brian Lam, Elena Younossi, Sean Felix, Mariam Ziayee, Jillian Kallman Price, Huong Pham, Leyla de Avila, (unknown), Patrick Austin, Thomas L. Jeffers, Carey Escheik, Pegah Golabi, Rebecca Cable, Manirath Srishord, Chapy Venkatesan, Linda Henry, Lynn H. Gerber, Zobair M. Younossi	31
3	Second victim experiences and moral injury as predictors of hospitalist burnout before and during the COVID-19 pandemic 2022 ·PLoS ONE ·(unknown), (unknown), (unknown), Leyla de Avila, (unknown), Chapy Venkatesan, Ali A. Weinstein, Zobair M. Younossi	15
4	Neutralizing Monoclonal Antibody Treatment Reduces Hospitalization for Mild and Moderate Coronavirus Disease 2019 (COVID-19): A Real-World Experience 2021 ·Clinical Infectious Diseases ·(unknown), Maria Stepanova, Brian Lam, Andrei Racila, (unknown), David W. Allen, (unknown), (unknown), (unknown), (unknown), Helen Stevens, (unknown), Linda Henry, Chapy Venkatesan, Lynn H. Gerber, (unknown), Jessica Jones, Zobair M. Younossi	48
5	Nonalcoholic Fatty Liver Disease and Alcoholic Liver Disease are Major Drivers of Liver Mortality in the United States 2020 ·Hepatology Communications ·James M. Paik, Pegah Golabi, Rakesh Biswas, Saleh A. Alqahtani, Chapy Venkatesan, Zobair M. Younossi	53
6	Liver Transplantation (LT) for Cryptogenic Cirrhosis (CC) and Nonalcoholic Steatohepatitis (NASH) Cirrhosis 2018 ·Medicine ·Pegah Golabi, Haley Bush, Maria Stepanova, Cameron T. Locklear, Ira M. Jacobson, Alita Mishra, (unknown), Madeline Erario, Chapy Venkatesan, Issah Younossi, Zachary Goodman, Zobair M. Younossi	57
7	Nonalcoholic Fatty Liver is Contributing to the Increase in Cases of Liver Disease in US Emergency Departments 2018 ·Journal of Clinical Gastroenterology ·Haley Bush, Pegah Golabi, Munkhzul Otgonsuren, Nila Rafiq, Chapy Venkatesan, Zobair M. Younossi	3
8	Demographics, Resource Utilization, and Outcomes of Elderly Patients With Chronic Liver Disease Receiving Hospice Care in the United States 2017 ·The American Journal of Gastroenterology ·Natsu Fukui, Pegah Golabi, Munkhzul Otgonsuren, Alita Mishra, Chapy Venkatesan, Zobair M. Younossi	21
9	Independent Predictors of Mortality and Resource Utilization in Viral Hepatitis Related Hepatocellular Carcinoma 2017 ·Annals of Hepatology ·Pegah Golabi, Thomas L. Jeffers, Zahra Younoszai, Munkhzul Otgonsuren, Mehmet Sayıner, Alita Mishra, Chapy Venkatesan, Zobair M. Younossi	18
10	Outcomes trends for acute myocardial infarction, congestive heart failure, and pneumonia, 2005-2009. 2016 ·PubMed ·Chapy Venkatesan, Alita Mishra, (unknown), (unknown), Linda Henry, Zobair M. Younossi	4
11	The outcomes of adult liver transplants in the United States from 1987 to 2013 2015 ·Liver International ·Maria Stepanova, (unknown), Sammy Saab, Alita Mishra, Chapy Venkatesan, Zobair M. Younossi	28
12	Association of nonalcoholic fatty liver disease (NAFLD) with hepatocellular carcinoma (HCC) in the United States from 2004 to 2009 breakdown → 2015 ·Hepatology ·Zobair M. Younossi, Munkhzul Otgonsuren, Linda Henry, Chapy Venkatesan, Alita Mishra, Madeline Erario, Sharon Hunt	593
13	Clinical outcomes and resource utilisation in Medicare patients with chronic liver disease: a historical cohort study 2014 ·BMJ Open ·Zobair M. Younossi, (unknown), Maria Stepanova, Chapy Venkatesan, Alita Mishra	28
14	Resource Utilization and Survival Among Medicare Patients with Advanced Liver Disease 2014 ·Digestive Diseases and Sciences ·Munkhzul Otgonsuren, Linda Henry, Sharon Hunt, Chapy Venkatesan, Alita Mishra, Zobair M. Younossi	9
15	Trends in Outpatient Resource Utilizations and Outcomes for Medicare Beneficiaries With Nonalcoholic Fatty Liver Disease 2014 ·Journal of Clinical Gastroenterology ·Zobair M. Younossi, (unknown), Maria Stepanova, Linda Henry, Chapy Venkatesan, Alita Mishra	40
16	Recent Trends in Inpatient Mortality and Resource Utilization for Patients with Stroke in the United States: 2005-2009 2013 ·Journal of Stroke and Cerebrovascular Diseases ·Maria Stepanova, Chapy Venkatesan, Laith Altaweel, Alita Mishra, Zobair M. Younossi	20
17	The inpatient economic and mortality impact of hepatocellular carcinoma from 2005 to 2009: analysis of the US nationwide inpatient sample 2013 ·Liver International ·Alita Mishra, Munkhzul Otgonsuren, Chapy Venkatesan, Mariam Afendy, Madeline Erario, Zobair M. Younossi	28
18	In-Hospital Mortality and Economic Burden Associated With Hepatic Encephalopathy in the United States From 2005 to 2009 2012 ·Clinical Gastroenterology and Hepatology ·Maria Stepanova, Alita Mishra, Chapy Venkatesan, Zobair M. Younossi	188
19	In patients with non-alcoholic fatty liver disease, metabolically abnormal individuals are at a higher risk for mortality while metabolically normal individuals are not 2012 ·Metabolism ·Zobair M. Younossi, Munkhzul Otgonsuren, Chapy Venkatesan, Alita Mishra	139
20	Subclinical unprofessionalism 2011 ·The Clinical Teacher ·Chapy Venkatesan	0

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact